Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular E
| Image |  |
|---|---|
| Description | scientific article published on 28 May 2016 |
| Author/s |
author: Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Investigators J Wouter Jukema Pierre Amarenco John J. P. Kastelein James Revkin Robert J Glynn Carla Yunis Paul Ridker Steven Nissen Wolfgang Koenig Jean-Claude Tardif |
| Publication date | May 28, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |